Serious infections caused by enteric gram-negative bacilli - Mechanisms of antibiotic resistance and implications for therapy of gram-negative sepsis in the transplanted patient

Seminars in Respiratory Infections

Volumn 17, Issue 4, 2002, Pages 260-264

  Paterson, David L ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFOTETAN; CEFOXITIN; CEPHALOSPORIN; CEPHALOSPORINASE; CEPHAMYCIN; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; DALFOPRISTIN; DAPTOMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PENICILLIN G; PIPERACILLIN; QUINOLONE; QUINUPRISTIN; SULBACTAM; TAZOBACTAM; TICARCILLIN;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ENTEROBACTER; ENTEROBACTERIACEAE; ENZYME ACTIVITY; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE MUTATION; GENETIC CODE; GRAM NEGATIVE INFECTION; NONHUMAN; ORGAN TRANSPLANTATION; PATHOGENESIS; PLASMID; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SEPSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

BACILLUS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; ORGAN TRANSPLANTATION; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 0036898574     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: 10.1053/srin.2002.36446     Document Type: Review

References (19)

1. Richards MJ, Edwards JR, Culver DH, et al: Nosocomial infections in medical intensive care units in the United States. Crit Care Med 27: 887-892, 1999
2. National Nosocomial infections Surveillance System: National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 29:404-421, 2001
3. Hanberger H, Garcia-Rodriguez JA, Gobernado M, et al: Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. JAMA 281:67-71, 1999
4. Bush K, Jacoby GA, Medeiros AA: A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39:1211-1233, 1995
5. Livermore DM: Clinical significance of β-lactamase induction and stable derepression in gram-negative rods. Eur J Clin Microbiol 6:439-445, 1987
6. Knothe H, Shah P, Krcmery V, et al: Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11:315-317, 1983
7. Brun-Buisson C, Legrand P, Arlet G, et al: Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 2:302-306, 1987
8. Sirot D, Sirot J, Labia R, et al: Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: Identification of CTX-1, a novel β-lactamase. J Antimicrob Chemother 20:323-334, 1987
9. Rebuck JA, Olsen KM. Fey PD, et al: Characterization of an outbreak due to extended-spectrum β-lactamase producing Klebsiella pneumoniae in a pediatric intensive care unit transplant population. Clin Infect Dis 31:1368-1372, 2000
10. Green M, Barbadora K: Recovery of ceftazidime-resistant Klebsiella pneumoniae from pediatric liver and intestinal transplant recipients. Pediatr Transplant 2:224-230, 1998
11. Paterson DL, Singh N, Rihs JD, et al: Control of an outbreak of infection due to extended-spectrum β-lactamaseproducing Escherichia coli in a liver transplantation unit. Clin Infect Dis 33:126-128, 2001
12. Paterson DL, Mulazimoglu L, Casellas JM, et al: Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 30:473-478, 2000
13. Lautenbach E, Strom BL, Bilker WB, et al: Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 33:1288-1294, 2001
14. Martinez-Martinez L, Pascual A, Jacoby GA: Quinolone resistance from a transferable plasmid. Lancet 351:797-799, 1998
15. Bradford PA, Urban C, Mariano N, et al: Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 41:563-569, 1997
16. Hawkey PM, Xiong J, Ye H, et al: Occurrence of a new metallo-β-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People's Republic of China. FEMS Microbiol Lett 194:53-57, 2001
17. Yan JJ, Ko WC, Wu JJ: Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-βlactamase, IMP-8, from a clinical isolate of Klebsielia pnuemoniae. Antimicrob Agents Chemother 45:2368-2371, 2001
18. Chow JW, Fine MJ, Shlaes DM, et al: Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115:585-590, 1991
19. Paterson DL, Ko WC, Von Gottberg A, et al: Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: Implications for the clinical microbiology laboratory. J Clin Microbiol 39:2206-2212, 2001